Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Autori principali: | , , , , , , , , , |
---|---|
Natura: | Conference item |
Pubblicazione: |
Oxford University Press
2017
|
_version_ | 1826286183963951104 |
---|---|
author | Ghazaly, E Woodcock, V Spilipoulou, P Spiers, L Moschandreas, J Griffiths, L Gnanaranjan, C Harrison, D Evans, T Blagden, S |
author_facet | Ghazaly, E Woodcock, V Spilipoulou, P Spiers, L Moschandreas, J Griffiths, L Gnanaranjan, C Harrison, D Evans, T Blagden, S |
author_sort | Ghazaly, E |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T01:40:00Z |
format | Conference item |
id | oxford-uuid:9688423b-aae7-44a4-ab1e-9d6810c56801 |
institution | University of Oxford |
last_indexed | 2024-03-07T01:40:00Z |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | dspace |
spelling | oxford-uuid:9688423b-aae7-44a4-ab1e-9d6810c568012022-03-26T23:53:32ZInterim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumorsConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:9688423b-aae7-44a4-ab1e-9d6810c56801Symplectic Elements at OxfordOxford University Press2017Ghazaly, EWoodcock, VSpilipoulou, PSpiers, LMoschandreas, JGriffiths, LGnanaranjan, CHarrison, DEvans, TBlagden, S |
spellingShingle | Ghazaly, E Woodcock, V Spilipoulou, P Spiers, L Moschandreas, J Griffiths, L Gnanaranjan, C Harrison, D Evans, T Blagden, S Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title | Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title_full | Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title_fullStr | Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title_full_unstemmed | Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title_short | Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors |
title_sort | interim pharmacokinetic pk and pharmacodynamic pd data from the first in human study of nuc 3373 a pyrimidine nucleotide analogue in patients with advanced solid tumors |
work_keys_str_mv | AT ghazalye interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT woodcockv interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT spilipouloup interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT spiersl interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT moschandreasj interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT griffithsl interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT gnanaranjanc interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT harrisond interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT evanst interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors AT blagdens interimpharmacokineticpkandpharmacodynamicpddatafromthefirstinhumanstudyofnuc3373apyrimidinenucleotideanalogueinpatientswithadvancedsolidtumors |